| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.59 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.37 | 0.07 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.34 | 2e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.32 | 2e-15 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.31 | 2e-12 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 2e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-11 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 0.0001 |